Literature DB >> 35348066

Vagus Nerve Stimulation for Tumor-Related Epilepsy: Does It Make Sense?

Keng Lam1, Jane Y Hwang.   

Abstract

Seizure is a common presenting symptom for those with brain tumor due to its unique pathogenesis. Several choices of antiepileptic drug are available to use, but some patients can still go on to develop tumor-related refractory epilepsy. Vagus nerve stimulation is becoming a popular option for those with medical refractory epilepsy but no brain tumor due to its effectiveness. There are very few studies available that address the topic of using vagus nerve stimulation for tumor-related epilepsy. Here we discuss the evidence of using vagus nerve stimulation for refractory tumor-related epilepsy and its challenges and gaps moving forward.

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 35348066      PMCID： PMC8784051          DOI： 10.7812/TPP/20.276

Source DB:  PubMed          Journal:  Perm J        ISSN： 1552-5767


  24 in total

Review 1.  The pathogenesis of tumor-related epilepsy and its implications for clinical treatment.

Authors:  Gan You; Zhiyi Sha; Tao Jiang
Journal:  Seizure       Date:  2012-02-01       Impact factor: 3.184

2.  Quality-of-life metrics with vagus nerve stimulation for epilepsy from provider survey data.

Authors:  Dario J Englot; Kevin H Hassnain; John D Rolston; Stephen C Harward; Saurabh R Sinha; Michael M Haglund
Journal:  Epilepsy Behav       Date:  2016-12-11       Impact factor: 2.937

3.  MRI of the brain is safe in patients implanted with the vagus nerve stimulator.

Authors:  S R Benbadis; J Nyhenhuis; W O Tatum; F R Murtagh; M Gieron; F L Vale
Journal:  Seizure       Date:  2001-10       Impact factor: 3.184

Review 4.  Seizures in glioma patients: An overview of incidence, etiology, and therapies.

Authors:  Niyatee Samudra; Tresa Zacharias; Aaron Plitt; Bradley Lega; Edward Pan
Journal:  J Neurol Sci       Date:  2019-07-19       Impact factor: 3.181

5.  Management of epilepsy in brain tumors.

Authors:  Marta Maschio; Umberto Aguglia; Giuliano Avanzini; Paola Banfi; Carla Buttinelli; Giuseppe Capovilla; Marina Maria Luisa Casazza; Gabriella Colicchio; Antonietta Coppola; Cinzia Costa; Filippo Dainese; Ornella Daniele; Roberto De Simone; Marica Eoli; Sara Gasparini; Anna Teresa Giallonardo; Angela La Neve; Andrea Maialetti; Oriano Mecarelli; Marta Melis; Roberto Michelucci; Francesco Paladin; Giada Pauletto; Marta Piccioli; Stefano Quadri; Federica Ranzato; Rosario Rossi; Andrea Salmaggi; Riccardo Terenzi; Paolo Tisei; Flavio Villani; Paolo Vitali; Lucina Carla Vivalda; Gaetano Zaccara; Alessia Zarabla; Ettore Beghi
Journal:  Neurol Sci       Date:  2019-08-07       Impact factor: 3.307

Review 6.  Clinical Management of Seizures in Patients With Low-Grade Glioma.

Authors:  Anna F Piotrowski; Jaishri Blakeley
Journal:  Semin Radiat Oncol       Date:  2015-02-23       Impact factor: 5.934

Review 7.  Epilepsy and brain tumors.

Authors:  Dario J Englot; Edward F Chang; Charles J Vecht
Journal:  Handb Clin Neurol       Date:  2016

8.  Seizure control outcomes after resection of dysembryoplastic neuroepithelial tumor in 50 patients.

Authors:  Edward F Chang; Catherine Christie; Joseph E Sullivan; Paul A Garcia; Tarik Tihan; Nalin Gupta; Mitchel S Berger; Nicholas M Barbaro
Journal:  J Neurosurg Pediatr       Date:  2010-01       Impact factor: 2.375

9.  Global incidence of malignant brain and other central nervous system tumors by histology, 2003-2007.

Authors:  Rebecca Leece; Jordan Xu; Quinn T Ostrom; Yanwen Chen; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2017-10-19       Impact factor: 12.300

Review 10.  Rates and Predictors of Seizure Freedom With Vagus Nerve Stimulation for Intractable Epilepsy.

Authors:  Dario J Englot; John D Rolston; Clinton W Wright; Kevin H Hassnain; Edward F Chang
Journal:  Neurosurgery       Date:  2016-09       Impact factor: 4.654
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.